Summit Therapeutics Inc. (SMMT) › Operating IncomeSummit Therapeutics Inc. (SMMT) — Operating IncomeAnnual figures by period end, from SEC filings.2019-01-31: $5.39M2020-12-31: -$53.19M2021-12-31: -$86.19M2022-12-31: -$72.09M2023-12-31: -$609.65M2024-12-31: -$226.00M-$226.00M2019-01-31Operating Income (USD)2024-12-31Period endedOperating IncomeChange YoYSource filing2024-12-31-$226.00M—2025-02-24From 2024-01-012023-12-31-$609.65M—2025-02-24From 2023-01-012022-12-31-$72.09M—2025-02-24From 2022-01-012021-12-31-$86.19M—2023-03-09From 2021-01-012020-12-31-$53.19M—2022-12-21From 2020-01-012019-01-31$5.39M—2021-03-31From 2018-02-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)